Retrospective chart review on natalizumab: Efficacy and safety of long-term treatment with natalizumab in Japanese patients with RRMS
Not Applicable
- Conditions
- Relapsing-Remitting Multiple Sclerosis
- Registration Number
- JPRN-UMIN000033924
- Lead Sponsor
- IRINO MEDICAL CLINIC, LLC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
Not provided
Exclusion Criteria
Refusal of consent by opt-out prior to the initiation of the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method